Refinement of vascular access port placement in nonhuman primates: complication rates and outcomes.
Chronic vascular access is often needed in experimental animal studies, and vascular access ports (VAP) have been proposed as an alternative to conventional venipuncture. We previously reported on VAP implantation by using femoral venous cutdown (FVC) and tunneling. In an attempt to decrease the moderate complications associated with the FVC method, we developed the single-incision, peripheral-insertion (SIPI) method. In a retrospective evaluation, 92 FVC procedures were compared with 113 SIPI procedures in cynomolgus and rhesus macaques and baboons with as much as 2.5 y of follow-up. The rate of complications was significantly lower for the SIPI method than for the FVC method (19.4% versus 33.7%), particularly in regard to infectious complications (8.0% versus 27.3%, respectively). In addition, VAP patency for blood sampling and fluid infusion was significantly better for the SIPI method than for the FVC method, with 1-y patency rate of 83% and 46%, respectively, and 2-y patency rate of 74% and 36%, respectively. Additional advantages of the SIPI method include the simplified implantation of the VAP and access in the homecage without any sedation or restraint after appropriate training of animals to cooperate. We conclude that the SIPI method presents an opportunity for refinement and is superior to the FVC method for chronic vascular access.
Department of Surgery, Schulze Diabetes Institute, University of Minnesota, Minneapolis, USA. graha066@umn.edu
Melanie L
ML
Graham
Lucas A
LA
Mutch
Eric F
EF
Rieke
Michele
M
Dunning
Elizabeth K
EK
Zolondek
Aaron W
AW
Faig
Bernhard J
BJ
Hering
Henk-Jan
HJ
Schuurman
D000818:Animals; D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000379:methods*; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000382:microbiology / Q000662:veterinary*; D008252:Macaca fascicularis / Q000601:surgery*; D008253:Macaca mulatta / Q000601:surgery*; D010215:Papio / Q000601:surgery*; D012189:Retrospective Studies
Contemp Top Lab Anim Sci. 2004 Nov;43(6):42-51
15669134
Lab Anim Sci. 1995 Feb;45(1):110-4
7752608
Contemp Top Lab Anim Sci. 2005 May;44(3):7-17
15934717
Lab Anim Care. 1969 Apr;19(2):237-9
4240232
Vet Surg. 1994 Mar-Apr;23(2):135-42
8191673
J Med Primatol. 2008 Aug;37(4):202-9
18331559
Contemp Top Lab Anim Sci. 1998 Sep;37(5):89-93
12456141
J Med Primatol. 2009 Jun;38(3):204-12
19220683
Lab Anim Sci. 1998 Oct;48(5):448-54
10090056
J Appl Anim Welf Sci. 2003;6(3):189-97
14612267
Am J Physiol. 1985 Sep;249(3 Pt 2):H681-4
4037112
Lab Anim Sci. 1983 Feb;33(1):90-4
6339808
Am J Primatol. 1993;30(1):55-74
31941178
J Clin Oncol. 1989 Feb;7(2):214-22
2915237
Lab Anim Sci. 1982 Jun;32(3):263-6
7098427
J Invest Surg. 1990;3(4):373-85
2291895
Psychoneuroendocrinology. 1993;18(5-6):383-95
8416048
Lab Anim Sci. 1990 Nov;40(6):643-4
2172635
Comp Med. 2001 Aug;51(4):349-56
11924794
Lab Anim Sci. 1994 Oct;44(5):491-4
7844959
Lab Anim Sci. 1988 Jun;38(3):279-81
3411914
Lab Anim Sci. 1986 Oct;36(5):507-11
3773463
J Am Vet Med Assoc. 2007 Mar 15;230(6):855-61
17362159
Contemp Top Lab Anim Sci. 2005 Mar;44(2):24-7
15773772
Lab Anim Sci. 1986 Aug;36(4):431-3
3773457
Am J Primatol. 1982;3(1-4):201-210
31992002
J Neuroimmunol. 1996 Aug;68(1-2):13-8
8784255
Lab Anim. 1985 Apr;19(2):138-44
3999687
J Am Vet Med Assoc. 2002 Feb 15;220(4):482-5
11860243
Lab Anim Sci. 1988 Apr;38(2):205-7
3374102
Brain Behav Immun. 1996 Mar;10(1):27-43
8735567
Contemp Top Lab Anim Sci. 1999 May;38(3):67-70
12086428